Davenport & Co’s Takeda Pharmaceutical TAK Stock Holding History

Davenport & Co’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$199K	Buy	+10,921	New	+$193K	﹤0.01%	1346
2024 Q4	–	Sell	-14,416	Closed	-$205K	–	1205
2024 Q3	$205K	Sell	14,416 -121	-0.8%	-$1.72K	﹤0.01%	1106
2024 Q2	$188K	Buy	14,537 +581	+4%	+$7.69K	﹤0.01%	1083
2024 Q1	$194K	Buy	13,956 +76	+0.5%	+$1.1K	﹤0.01%	1072
2023 Q4	$198K	Buy	13,880 +76	+0.6%	+$1.08K	﹤0.01%	1019
2023 Q3	$214K	Sell	13,804 -198	-1%	-$3.06K	﹤0.01%	969
2023 Q2	$220K	Buy	14,002 +2,555	+22%	+$41.9K	﹤0.01%	975
2023 Q1	$189K	Buy	+11,447	New	+$182K	﹤0.01%	992

Other funds holding TAK

LWAM

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MLFP

MPS Loria Financial Planners Burr Ridge, Illinois $527M AUM 17.98% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return

Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return

Davenport & Co's TAK Position: Q3 2026 in Review

Davenport & Co opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 10,921 shares worth $199K. The stake represents ﹤0.01% of the portfolio and ranks #1346 among its holdings. This is a return to the name: Davenport & Co previously reported a position in TAK as recently as Q3 2024.

Davenport & Co first reported a position in TAK in Q1 2023 and has held it in 8 quarters since. The position peaked at $220K in Q2 2023. 26 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

Davenport & Co held 10,921 shares of Takeda Pharmaceutical worth $199K as of Q3 2026.
Takeda Pharmaceutical was a new Davenport & Co position in Q3 2026.
Takeda Pharmaceutical made up ﹤0.01% of Davenport & Co's portfolio in Q3 2026, its #1346 holding.
Davenport & Co first reported a position in Takeda Pharmaceutical in Q1 2023 and has held it in 8 quarters since.
Davenport & Co's Takeda Pharmaceutical position peaked at $220K in Q2 2023.
26 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.